Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 48

1.

In vitro antibacterial activity of AZD0914 against human Mycoplasmas and Ureaplasmas.

Waites KB, Crabb DM, Duffy LB, Huband MD.

Antimicrob Agents Chemother. 2015;59(6):3627-9. doi: 10.1128/AAC.04945-14. Epub 2015 Mar 30.

2.

Comparison of the illumigene Mycoplasma DNA amplification assay and culture for detection of Mycoplasma pneumoniae.

Ratliff AE, Duffy LB, Waites KB.

J Clin Microbiol. 2014 Apr;52(4):1060-3. doi: 10.1128/JCM.02913-13. Epub 2014 Jan 15.

3.

Transplacental transfer of Azithromycin and its use for eradicating intra-amniotic ureaplasma infection in a primate model.

Acosta EP, Grigsby PL, Larson KB, James AM, Long MC, Duffy LB, Waites KB, Novy MJ.

J Infect Dis. 2014 Mar;209(6):898-904. doi: 10.1093/infdis/jit578. Epub 2013 Oct 31.

4.

Maternal azithromycin therapy for Ureaplasma intraamniotic infection delays preterm delivery and reduces fetal lung injury in a primate model.

Grigsby PL, Novy MJ, Sadowsky DW, Morgan TK, Long M, Acosta E, Duffy LB, Waites KB.

Am J Obstet Gynecol. 2012 Dec;207(6):475.e1-475.e14. doi: 10.1016/j.ajog.2012.10.871. Epub 2012 Oct 23.

5.

Standardized methods and quality control limits for agar and broth microdilution susceptibility testing of Mycoplasma pneumoniae, Mycoplasma hominis, and Ureaplasma urealyticum.

Waites KB, Duffy LB, Bébéar CM, Matlow A, Talkington DF, Kenny GE, Totten PA, Bade DJ, Zheng X, Davidson MK, Shortridge VD, Watts JL, Brown SD.

J Clin Microbiol. 2012 Nov;50(11):3542-7. doi: 10.1128/JCM.01439-12. Epub 2012 Aug 22.

6.

Comparative genome analysis of 19 Ureaplasma urealyticum and Ureaplasma parvum strains.

Paralanov V, Lu J, Duffy LB, Crabb DM, Shrivastava S, Methé BA, Inman J, Yooseph S, Xiao L, Cassell GH, Waites KB, Glass JI.

BMC Microbiol. 2012 May 30;12:88. doi: 10.1186/1471-2180-12-88.

7.

Chromosomal mutations responsible for fluoroquinolone resistance in Ureaplasma species in the United States.

Xiao L, Crabb DM, Duffy LB, Paralanov V, Glass JI, Waites KB.

Antimicrob Agents Chemother. 2012 May;56(5):2780-3. doi: 10.1128/AAC.06342-11. Epub 2012 Feb 27.

8.

Genotypic characterization of ureaplasma serovars from clinical isolates by pulsed-field gel electrophoresis.

Xiao L, Crabb DM, Moser SA, Duffy LB, Glass JI, Paralanov V, Waites KB.

J Clin Microbiol. 2011 Sep;49(9):3325-8. doi: 10.1128/JCM.01235-11. Epub 2011 Jul 27.

9.

Extensive horizontal gene transfer in ureaplasmas from humans questions the utility of serotyping for diagnostic purposes.

Xiao L, Paralanov V, Glass JI, Duffy LB, Robertson JA, Cassell GH, Chen Y, Waites KB.

J Clin Microbiol. 2011 Aug;49(8):2818-26. doi: 10.1128/JCM.00637-11. Epub 2011 Jun 22.

10.

Mutations in ribosomal proteins and ribosomal RNA confer macrolide resistance in human Ureaplasma spp.

Xiao L, Crabb DM, Duffy LB, Paralanov V, Glass JI, Hamilos DL, Waites KB.

Int J Antimicrob Agents. 2011 Apr;37(4):377-9. doi: 10.1016/j.ijantimicag.2010.12.012. Epub 2011 Feb 24.

PMID:
21353494
11.

Critical role of macrophages and their activation via MyD88-NFκB signaling in lung innate immunity to Mycoplasma pneumoniae.

Lai JF, Zindl CL, Duffy LB, Atkinson TP, Jung YW, van Rooijen N, Waites KB, Krause DC, Chaplin DD.

PLoS One. 2010 Dec 23;5(12):e14417. doi: 10.1371/journal.pone.0014417.

12.

Detection and characterization of human Ureaplasma species and serovars by real-time PCR.

Xiao L, Glass JI, Paralanov V, Yooseph S, Cassell GH, Duffy LB, Waites KB.

J Clin Microbiol. 2010 Aug;48(8):2715-23. doi: 10.1128/JCM.01877-09. Epub 2010 Jun 16.

13.

Emerging macrolide resistance in Mycoplasma pneumoniae in children: detection and characterization of resistant isolates.

Li X, Atkinson TP, Hagood J, Makris C, Duffy LB, Waites KB.

Pediatr Infect Dis J. 2009 Aug;28(8):693-6. doi: 10.1097/INF.0b013e31819e3f7a.

PMID:
19633515
14.

Deficient immune response to Mycoplasma pneumoniae in childhood asthma.

Atkinson TP, Duffy LB, Pendley D, Dai Y, Cassell GH.

Allergy Asthma Proc. 2009 Mar-Apr;30(2):158-65. doi: 10.2500/aap.2009.30.3207.

PMID:
19463205
15.

Comparative in vitro susceptibilities of human mycoplasmas and ureaplasmas to a new investigational ketolide, CEM-101.

Waites KB, Crabb DM, Duffy LB.

Antimicrob Agents Chemother. 2009 May;53(5):2139-41. doi: 10.1128/AAC.00090-09. Epub 2009 Mar 2.

16.

Comparative in vitro activities of the investigational fluoroquinolone DC-159a and other antimicrobial agents against human mycoplasmas and ureaplasmas.

Waites KB, Crabb DM, Duffy LB.

Antimicrob Agents Chemother. 2008 Oct;52(10):3776-8. doi: 10.1128/AAC.00849-08. Epub 2008 Jul 28.

17.
19.

Genotypic characterization of Ureaplasma species by pulsed field gel electrophoresis.

Moser SA, Mayfield CA, Duffy LB, Waites KB.

J Microbiol Methods. 2006 Dec;67(3):606-10. Epub 2006 Jul 21.

PMID:
16859785
20.

A role for the Mycoplasma pneumoniae adhesin P1 in interleukin (IL)-4 synthesis and release from rodent mast cells.

Hoek KL, Duffy LB, Cassell GH, Dai Y, Atkinson TP.

Microb Pathog. 2005 Oct;39(4):149-58.

PMID:
16169702
Items per page

Supplemental Content

Loading ...
Write to the Help Desk